Pterygium recurrence is frequent after simple excision alone, especially in hot dry climates.' Beta irradiation is the only treatment that considerably reduces the recurrence rate, and it is frequently used after excision of primary pterygia.2 Complications of beta irradiation for this nonmalignant lesion have received little attention. Scleral necrosis from beta irradiation after pterygium excision was first described by Jones and Reese3 and subsequently by Cameron, 45 Cappin, 6 and Talbot.7 This complication may occur years after beta irradiation and leads to a chronically irritable eye.
Pseudomonas endophthalmitis in such eyes has been reported only once.4 This paper reports 3 cases seen over 1 year and emphasises the importance of surgical repair of radiation-induced scleral ulceration.
Case reports CASE 1
A 56-year-old European man had bilateral nasal pterygia excised leaving bare sclera in 1968. A total dose of 4000 rads of beta irradiation was applied to each eye over 2 weeks in 3 doses beginning on the 4th postoperative day. An oval strontium-90 applicator with an emission rate of 870 rads min-' and an active area of 18 x 13 mm was used.
The patient was asymptomatic until 1978, when the left eye became red and painful 3 days after it had been hit by a block of wood. On admission the visual acuity was counting fingers. The eye was hyperaemic with a copious mucopurulent discharge. A large necrotic scleral ulcer 6 mm in diameter Hourly gentamicin drops and intramuscular tobramycin (120 mg 8 hourly) were given for 3 days, but the eye deteriorated. Therefore treatment was changed to intravenous ticarcillin via a superior vena cava catheter (4 g in 20 ml normal saline infused over 10 minutes every 4 hours, that is, 24 g/day or 300 mg/kg/day) for 6 weeks together with oral probenecid 2 g daily. Tobramycin was given by subconjunctival injection (10 mg daily) for 2 weeks by continuous infusion into the upper fornix (320 mg 1-1 normal saline at 0 3 ml min-') for the second 2 weeks and then by oculentum tobramycin 0-30X6 times a day for 2 weeks. Six weeks after the patient's admission to hospital a conjunctival flap was placed over the ulcer, and antibiotics ceased 1 week later.
The right visual acuity was 6/5. An avascular thin cystic conjunctiva extended from 2 to 4 o'clock surrounded by tufts of episcleral vessels. The subjacent sclera was porcelain white. One year later the left visual acuity was 6/9. The sclera was well covered by conjunctiva. A superficial corneal opacity, posterior synechiae, moderate lens opacities, and membranous vitreous opacities were present (Fig. 2) .
Early admission to hospital and intense and prolonged treatment were important factors in salvaging this eye. The ulcer site and size indicated that radiation-induced scleral pathology predisposed to the subsequent ulceration and infection. A 57-year-old Aboriginal woman had bilateral nasal pterygia excised leaving bare sclera in 1976.
A total dose of 2400 rads of beta irradiation was applied over 2 weeks in 3 doses beginning on the day of operation. The applicator and dose rate were similar to that described above. In September 1978 she presented with a 2-week history of a red painful photophobic eye. The visual acuity was right 6/12 and left 6/36. The reduced vision was due to lens opacities. Scleral necrosis was present medially in each eye, 2 mm from the limbus and 2 mm in diameter. The ulceration was almost full thickness with a grey-brown base composed of a thin layer of scleral fibres. The left eye was hyperaemic, with an iridocyclitis and corneal oedema. No organisms were cultured from conjunctival swabs. The eye settled with topical treatment, and 3 weeks later the left ulcer was closed with a scleral graft and conjunctival flap.
In June 1979 the patient was readmitted with a 1-week history of a right conjunctivitis progressing despite topical chloramphenicol and systemic amoxycillin. There was no history of trauma. The right eye had light perception only, gross periorbital oedema, marked conjunctival hyperaemia, corneal oedema, and a 360°peripheral ring hypoyon.
The scleral ulceration was unchanged (Fig. 3) . 
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Pseudomonas aeruginosa was repeatedly cultured from conjunctival swabs. Despite systemic gentamycin (120 mg daily) and carbenicillin (2 g daily) and topical gentamycin and chloramphenicol the condition of the eye worsened, and it was eviscerated 8 days after admission. The left eye had healed well (Fig. 4) .
The bilateral nature of the deep scleral ulceration, the successful outcome of the operated eye, and the subsequent pseudomonas endophthalmitis and loss of the fellow eye serve to emphasise the importance of repairing scleral ulceration after beta irradiation.
Discussion
Pseudomonas aeruginosa is widely distributed in nature and can be found in water, soil, waste, and as a commensal of the intestinal tract and skin. The commonest ocular infection is a hypopyon corneal ulcer or abscess. Prior epithelial damage is often present. Rarely it causes postoperative endophthalmitis, lid infection, primary conjunctivitis, dacryocystitis, or orbital cellulitis.8 It is a classical opportunist, and infection particularly arises in patients predisposed by defective immunity or altered commensal flora by broad-spectrum antibiotics.
Radiation-induced scleral necrosis is an uncommon but an increasingly recognised complication of pterygium management. The above cases are from a group of over 40 patients seen recently in Western Australia with scleral ulceration. No longer can the sclera be considered resistant to radiation necrosis even after modest dosages of beta irradiation.
Infection in eyes with scleral disease has not been previously emphasised. No mention has been made of bacterial endophthalmitis as a complication of necrotising scleritis.9 10 However, pseudomonas endophthalmitis is a significant complication of beta irradiation-induced scleral ulceration. It occurred in one of 6 cases reported by Cameron.4 Talbot7 reported 13 cases of conjunctival and scleral ulceration of which two developed 'perforation, uveitis and blindness', but there is no mention of infection. Our cases indicate that pseudomonas may arise spontaneously in eyes with scleral ulceration even when this is only partial thickness. Such defects therefore should be repaired by a conjunctival flap or by a graft of sclera, cornea, fascia lata, or other tissue to prevent this devastating infection.
There is no ready explanation for the occurrence of pseudomonas infection in irradiation-induced scleral disease but apparently not in necrotising scleritis. Certainly scleral destruction is more extensive after scleritis than irradiation. Suppression of the immunological apparatus by x-irradiation is well known. However, experimentally Silverstein" has clearly shown that ocular irradiation has no effect on the activation of the immune system towards foreign antigens induced into the eye. The large scleral ulcerations in cases 1 and 2 are atypical of beta irradiation-induced ulcers, which usually do not involve the cornea and are rarely as extensive. Most probably pseudomonas proteases extended the ulceration.
Salvage of one eye must be attributed to early, prolonged, and intensive antibiotic treatment. Persistence of pseudomonas organisms despite treatment and recrudescence of the infection after treatment is ended has been well described'2 and is an important factor in the management of pseudomonas infections. Prolonged treatment is therefore essential, and a continuous local delivery system is advocated.'2 This not only delivers the antibiotic continuously with minimal discomfort but also washes away pus, debris, and pseudomonas proteases. Antibiotic effectiveness is enhanced and further destruction of ocular tissue is minimised. The alternative-repeated subconjunctival injections-is extremely painful and irritative, so that the number of repeated injections is limited.
Synergism between ticarcillin and tobramycin has been demonstrated in vitro and in vivo.'3 Adequate aqueous levels of tobramycin occur with subconjunctival and topical use.'4 Ticarcillin is more effective than carbenicillin against pseudomonas.15 When pseudomonas organisms resistant to gentamicin or carbenicillin are present, or when the clinical response is inadequate, the combination of ticarcillin and tobramycin should be used.
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